The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.50
Bid: 160.00
Ask: 165.00
Change: -2.50 (-1.52%)
Spread: 5.00 (3.125%)
Open: 165.00
High: 165.00
Low: 162.50
Prev. Close: 165.00
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Patent Filed for Plant-Based Ingredient

3 Feb 2022 07:00

RNS Number : 5350A
Itaconix PLC
03 February 2022
 

Itaconix plc

("Itaconix" or the "Company")

 

New Patent Filed for Plant-Based Ingredient

 

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products, is pleased to announce that the Company is extending the Itaconix technology platform into potential uses in composite materials and has filed a new patent to protect innovative intellectual property for expected applications in this new area.

The extension of the Itaconix technology platform is part of the Company's efforts to engage with potential customers to identify sizable unmet needs that Itaconix can address with plant-based solutions.

Market and materials research led by Dr Yvon Durant, Itaconix's CTO, has created a path to making certain composite materials that may allow a safer process to produce products that also have higher plant-based content. If granted, the patent will protect a new family of intellectual property for Itaconix. The review process for the filing is expected to take at least two years, and there is no guarantee that the patent will be granted.

Product research based on this patent filing will now enter the next stage of commercial development. Key milestones for 2022 are to complete initial environmental and safety studies and to engage in commercial discussions with market collaborators. Potential revenues are not expected until at least 2024, which is a normal timeframe for new product development.

The Company estimates that a $600 million per annum addressable market exists for potential Itaconix products based on this new technology.

John R. Shaw, CEO of Itaconix, said:

"Although the usual steps remain to advance a new product to market, we are very excited that our plant-based solutions have the potential to address major unmet customer needs. This patent filing marks a significant milestone in our efforts to deliver safety and sustainability to new categories of consumer products."

 

Enquiries:

 

Itaconix

+1 (603) 775 4400

John R. Shaw/Laura Denner

Belvedere Communications

+44 (0) 20 3687 2756

John West/Llew Angus

finnCap

+44 (0) 20 7220 0500

Ed Frisby/Abigail Kelly/Milesh Hindocha - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's contributions to the global low carbon economy are recognised by the London Stock Exchange's Green Economy Mark.

www.itaconix.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLLLBLLLFBBD
Date   Source Headline
24th Jan 20144:46 pmRNSHolding(s) in Company
10th Jan 20147:00 amRNSBlock Listing Six Monthly Return
20th Nov 20137:00 amRNSMarketing approval of nicotine gum in Europe
17th Oct 20137:00 amRNSSupply and Distribution Agreement with Amma Polska
11th Oct 20137:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Sep 20137:00 amRNSInterim Results
1st Aug 20137:00 amRNSTotal Voting Rights
22nd Jul 20137:00 amRNSAward of contract to supply nicotine gum
15th Jul 201312:20 pmRNSChange of Registered Office
9th Jul 20137:00 amRNSBlocklisting Interim Review
28th May 20132:02 pmRNSResult of AGM
17th Apr 20134:47 pmRNSHolding(s) in Company
17th Apr 20137:00 amRNSDirector's Dealings
9th Apr 20137:00 amRNSPositive test results for encapsulation technology
22nd Mar 20137:00 amRNSNotice of AGM and Posting of Annual Report
13th Mar 20137:00 amRNSPreliminary Results
1st Mar 20137:00 amRNSTotal Voting Rights
1st Feb 20132:42 pmRNSNotice of patent infringement proceedings
10th Jan 20137:01 amRNSAwards under Long Term Incentive Plan
10th Jan 20137:00 amRNSBlock Listing
8th Jan 20131:59 pmRNSHolding(s) in Company
19th Dec 20122:14 pmRNSEstablishment of Employee Benefit Trust
19th Dec 20127:00 amRNSTrading Update
25th Sep 20127:00 amRNSInterim Results
13th Sep 20127:00 amRNSBoard Appointment
17th Aug 20127:00 amRNSIssue of Warrants
30th Jul 20127:00 amRNSCanadian Distribution Deals Won
10th Jul 20128:09 amRNSBoard Appointment
10th Jul 20128:05 amRNSAIM Admission - First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.